blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1863572

EP1863572 - NEW CLASS OF T CELLS ACTIVATORS AND USE THEREOF [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  06.07.2012
Database last updated on 19.10.2024
Most recent event   Tooltip06.07.2012Application deemed to be withdrawnpublished on 08.08.2012  [2012/32]
Applicant(s)For all designated states
Innate Pharma
Immeuble Grand Pré, 121, ancien Chemin de Cassis
13009 Marseille / FR
[N/P]
Former [2007/50]For all designated states
Innate Pharma
Immeuble Grand Pré, 121, ancien chemin de Cassis
13009 Marseille / FR
Inventor(s)01 / BELMANT, Christian
36 Impasse du Hameau de la Tour
F-83140 Six-Fours-Les-Plages / FR
 [2007/50]
Representative(s)Gallois, Valérie, et al
Cabinet BECKER & ASSOCIES
25, rue Louis Le Grand
75002 Paris / FR
[N/P]
Former [2007/50]Gallois, Valérie, et al
Cabinet BECKER & ASSOCIES 25, rue Louis Le Grand
75002 Paris / FR
Application number, filing date06755866.821.03.2006
[2007/50]
WO2006IB01206
Priority number, dateUS20050663726P22.03.2005         Original published format: US 663726 P
[2007/50]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2006103568
Date:05.10.2006
Language:EN
[2006/40]
Type: A2 Application without search report 
No.:EP1863572
Date:12.12.2007
Language:EN
The application published by WIPO in one of the EPO official languages on 05.10.2006 takes the place of the publication of the European patent application.
[2007/50]
Search report(s)International search report - published on:EP29.03.2007
ClassificationIPC:A61P35/00, C07F9/02, A61K31/66
[2007/50]
CPC:
C07F9/113 (EP,US); A61K31/66 (KR); A61P11/06 (EP);
A61P19/02 (EP); A61P25/00 (EP); A61P29/00 (EP);
A61P3/10 (EP); A61P31/00 (EP); A61P31/04 (EP);
A61P31/06 (EP); A61P31/16 (EP); A61P31/18 (EP);
A61P31/22 (EP); A61P33/06 (EP); A61P35/00 (EP);
A61P35/04 (EP); A61P37/06 (EP); A61P37/08 (EP);
A61P43/00 (EP); C07F9/02 (KR) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2007/50]
Extension statesAL03.09.2007
BA03.09.2007
HR03.09.2007
MK03.09.2007
YU03.09.2007
TitleGerman:NEUE T-ZELLAKTIVATORKLASSE UND VERWENDUNG[2007/50]
English:NEW CLASS OF T CELLS ACTIVATORS AND USE THEREOF[2007/50]
French:NOUVELLE CLASSE D'ACTIVATEURS DE CELLULES T ET UTILISATION CORRESPONDANTE[2007/50]
Entry into regional phase03.09.2007National basic fee paid 
03.09.2007Designation fee(s) paid 
03.09.2007Examination fee paid 
Examination procedure03.09.2007Amendment by applicant (claims and/or description)
03.09.2007Examination requested  [2007/50]
15.06.2009Despatch of a communication from the examining division (Time limit: M06)
14.12.2009Reply to a communication from the examining division
01.08.2011Despatch of a communication from the examining division (Time limit: M06)
12.02.2012Application deemed to be withdrawn, date of legal effect  [2012/32]
19.03.2012Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2012/32]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  15.06.2009
Fees paidRenewal fee
03.09.2007Renewal fee patent year 03
02.03.2009Renewal fee patent year 04
18.03.2010Renewal fee patent year 05
29.03.2011Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
31.03.201207   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[I]WO2004050096  (INNATE PHARMA [FR], et al) [I] 1-28 * page 47 - page 49; examples 2,9; claims 40-42 *
ExaminationUS6984635
    - THORNBER C.W., "Isosterism and molecular modification in drug design", CHEMICAL SOCIETY REVIEWS, (19790101), vol. 8, no. 4, pages 563 - 580, XP000953019

DOI:   http://dx.doi.org/10.1039/cs9790800563
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.